Supplementary Table 3.
Analysis of Lymphocyte Subsets in Patients Infected With SARS-CoV-2
| Characteristic | Patients (n = 30) | Diarrhea group (n = 15) | Non-diarrhea group (n = 15) | P value |
|---|---|---|---|---|
| CD3+ T cells (%; normal range 58.17–84.22) | 74.74 ± 8.15 | 74.69 ± 6.41 | 74.80 ± 10.59 | .973 |
| CD4+ T cells (%; normal range 24.34–51.37) | 42.41 ± 10.20 | 42.12 ± 12.61 | 42.82 ± 6.33 | .849 |
| CD8+ T cells (%; normal range 14.23–38.95) | 27.55 ± 10.13 | 27.66 ± 11.45 | 27.39 ± 8.75 | .943 |
| B cells (%; normal range 4.10–18.31) | 12.15 ± 3.26 | 11.64 ± 2.69 | 12.96 ± 4.09 | .305 |
| NK cells (%; normal range 3.33–30.47) | 9.96 ± 7.06 | 10.50 ± 6.78 | 9.10 ± 7.95 | .608 |
| CD4+/CD8+ ratio (normal range 0.41–2.72) | 2.11 ± 2.22 | 2.40 ± 2.91 | 1.72 ± 0.58 | .382 |
NK, natural killer; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.